Teyi Pharmaceutical Group Co.,Ltd (SHE:002728)
China flag China · Delayed Price · Currency is CNY
9.29
-0.20 (-2.11%)
May 20, 2026, 2:25 PM CST

SHE:002728 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Jan '22
Operating Revenue
838.55923.81686.911,066886.15757.93
Other Revenue
0.720.720.880.740.430.23
839.27924.53687.791,067886.57758.16
Revenue Growth (YoY)
2.56%34.42%-35.55%20.38%16.94%19.83%
Cost of Revenue
398.93421.17386.47467.98451.83356.12
Gross Profit
440.34503.36301.32599.23434.74402.04
Selling, General & Admin
317.36371.5225.54240.67176.38175.95
Research & Development
44.1444.4143.3343.0638.0137.78
Other Operating Expenses
4.997.912.059.381.759.27
Operating Expenses
365.31422.54270.89293.19216.74224.72
Operating Income
75.0380.8230.43306.04217.99177.33
Interest Expense
-3.16-4.23-5.32-16.36-29.13-29.51
Interest & Investment Income
3.713.5710.3412.348.5512.14
Other Non Operating Income (Expenses)
0.610.37-0.45-0.4-1.44-0.42
EBT Excluding Unusual Items
76.1980.5334.99301.61195.97159.53
Impairment of Goodwill
---11.63-13.17--23.06
Gain (Loss) on Sale of Assets
-0.01-0.070.010.120.040.1
Asset Writedown
-0.82-0.82-0.16-0.27-0.12-0.37
Other Unusual Items
2.642.64-1.164.70.4310.91
Pretax Income
7882.2822.05292.99196.32147.1
Income Tax Expense
2.140.611.5639.8218.1220.18
Net Income
75.8781.6720.5253.18178.2126.92
Net Income to Common
75.8781.6720.5253.18178.2126.92
Net Income Growth
76.82%298.50%-91.91%42.07%40.41%189.66%
Shares Outstanding (Basic)
508510512460438401
Shares Outstanding (Diluted)
508510512460438401
Shares Change (YoY)
-4.11%-0.38%11.31%5.16%9.09%2.75%
EPS (Basic)
0.150.160.040.550.410.32
EPS (Diluted)
0.150.160.040.550.410.32
EPS Growth
84.39%300.00%-92.73%35.10%28.71%181.91%
Free Cash Flow
92.71164.54-136.11112.51281.39147.24
Free Cash Flow Per Share
0.180.32-0.270.240.640.37
Dividend Per Share
0.1500.1500.0500.3570.3320.332
Dividend Growth
200.00%200.00%-86.00%7.69%--
Gross Margin
52.47%54.45%43.81%56.15%49.04%53.03%
Operating Margin
8.94%8.74%4.42%28.68%24.59%23.39%
Profit Margin
9.04%8.83%2.98%23.72%20.10%16.74%
Free Cash Flow Margin
11.05%17.80%-19.79%10.54%31.74%19.42%
EBITDA
146.21150.6494.79366.14270.52228.63
EBITDA Margin
17.42%16.29%13.78%34.31%30.51%30.16%
D&A For EBITDA
71.1869.8264.3760.152.5251.31
EBIT
75.0380.8230.43306.04217.99177.33
EBIT Margin
8.94%8.74%4.42%28.68%24.59%23.39%
Effective Tax Rate
2.74%0.74%7.06%13.59%9.23%13.72%
Revenue as Reported
839.27924.53687.791,067886.57758.16
Source: S&P Global Market Intelligence. Standard template. Financial Sources.